PHASE-I CLINICAL-EVALUATION OF ORAL AND INTRAVENOUS 4-DEMETHOXYDAUNORUBICIN

被引：6
|
作者：
KAVANAGH, JJ
YEUNG, KY
SAVARAJ, N
KRAKOFF, IH
机构：
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 10期
关键词：
D O I：
10.1016/0277-5379(85)90013-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1187 / 1189
页数：3
相关论文
共 50 条
  • [41] PHASE-I CLINICAL EVALUATION OF ANGUIDINE
    MURPHY, WK
    BURGESS, MA
    VALDIVIESO, M
    LIVINGSTON, RB
    BODEY, GP
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1978, 62 (10): : 1497 - 1502
  • [42] A PHASE-I STUDY OF INTRAVENOUS IODODEOXYURIDINE AS A CLINICAL RADIOSENSITIZER
    KINSELLA, TJ
    RUSSO, A
    MITCHELL, JB
    COLLINS, JM
    ROWLAND, J
    WRIGHT, D
    GLATSTEIN, E
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (11): : 1941 - 1946
  • [43] PHASE-II STUDY OF 4-DEMETHOXYDAUNORUBICIN IN ADVANCED OVARIAN-CARCINOMA
    HAKES, TB
    DAGHESTANI, AN
    DOUGHERTY, JB
    WEISELBERG, L
    RAYMOND, V
    CANCER TREATMENT REPORTS, 1985, 69 (05): : 559 - 560
  • [44] PHASE-II TRIAL OF 4-DEMETHOXYDAUNORUBICIN IN ADVANCED COLORECTAL-CARCINOMA
    HARPER, HD
    KEMENY, NE
    AHMED, T
    CHENG, E
    ARENA, F
    SORDILLO, P
    FAYE, L
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 689 - 690
  • [45] PHASE-I EVALUATION OF INTRAVENOUS DIFLUOROMETHYLORNITHINE - A POLYAMINE INHIBITOR
    MADDOX, AM
    KEATING, MJ
    MCCREDIE, KE
    ESTEY, E
    FREIREICH, EJ
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (03) : 287 - 292
  • [46] PHASE-I STUDY OF INTRAVENOUS 4-HYDROXYANISOLE
    RUSTIN, GJ
    STRATFORD, MR
    LAMONT, A
    BLEEHEN, N
    PHILIP, PA
    HOWELLS, N
    WATFA, RR
    SLACK, JA
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) : 1362 - 1364
  • [47] PHASE-II TRIAL OF ORAL 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    KRIS, MG
    GRALLA, RJ
    KELSEN, DP
    CASPER, ES
    BURKE, MT
    FIORE, JJ
    CIBAS, IR
    HEELAN, RT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 377 - 379
  • [48] PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF ORAL 4-DEMETHOXYDAUNORUBICIN IN ADVANCED NON-PRETREATED SMALL-CELL LUNG-CANCER
    MILROY, R
    CUMMINGS, J
    KAYE, SB
    BANHAM, SW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (01) : 75 - 77
  • [49] PHASE-II STUDY OF ORAL 4-DEMETHOXYDAUNORUBICIN IN PREVIOUSLY TREATED (EXCEPT ANTHRACYCLINES) METASTATIC BREAST-CANCER PATIENTS
    KOLARIC, K
    MECHL, Z
    POTREBICA, V
    SOPKOVA, B
    ONCOLOGY, 1987, 44 (02) : 82 - 86
  • [50] PHARMACOKINETICS OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN IMI-30 NSC 256439) FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION IN PATIENTS WITH ADVANCED CANCER
    GILLIES, HC
    HERRIOTT, D
    LIANG, R
    OHASHI, K
    ROGERS, HJ
    HARPER, PG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (03) : 303 - 310
12345